Relentless Curing Age-Related Diseases w Epigenetic Medicines | Lada Nuzhna, General Control
30 snips
Nov 20, 2025 
Lada Nuzhna, Founder and CEO of General Control, specializes in epigenetic therapies for age-related diseases. She shares her fascinating journey from physics to aging research, driven by a passion for extending healthy life. Lada discusses the transformative power of the epigenome and her innovative approach to disease-driving gene expression. With insights on funding, early human trials in China, and the challenges of aging research, she emphasizes the importance of agile biotech teams. Her personal story of growing up in Eastern Ukraine adds depth to her visionary ambitions in longevity.
AI Snips
Chapters
Transcript
Episode notes
IsoBiotech's Fast Exit Example
- Small European biotech IsoBiotech reached human data quickly and sold to AstraZeneca for about $1B.
- They achieved it in under four years by running trials in China to accelerate timelines.
Leaving Home At 14 Shaped Her Drive
- Lada left home at 14 after schools closed due to war in eastern Ukraine and struggled to find schooling.
- Her hometown later became rubble and was taken over in 2024, shaping her resilience.
Favor Engineering Risk Over New Biology
- Focus on product-direction and avoid sprawling scientific risk early in startups.
- Prioritize engineering risk over unknown scientific risk to reach patients faster.